Stocks股票 / Health Care / ELAN
ELAN US listed · USD美股 · 美元
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested.Elanco Animal Health Incorporated是一家美国制药公司,为宠物和牲畜生产药品和疫苗。直至2019年,该公司曾是礼来公司的子公司,之后被剥离。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-06Estimates being raised — 2 analysts预期上调 — 2 位分析师
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | ELAN | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 1.91x | 3.44 | |
| P/S市销率 | 2.65x | 2.97 | |
| Earnings yield盈利收益率 | -1.86% | 2.72 | |
| FCF yield自由现金流收益率 | 2.27% | 4.00 | |
| P/FCF市值/自由现金流 | 43.99x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: +$0.9M net (4 buyers, 0 sellers)+$0.9M 净值(4 买家,0 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested.Elanco Animal Health Incorporated是一家美国制药公司,为宠物和牲畜生产药品和疫苗。直至2019年,该公司曾是礼来公司的子公司,之后被剥离。
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 1.9× | 3.4× | 75% |
| Price / Sales市销率 | 2.6× | 3.0× | 55% |
| Earnings yield盈利收益率 | -1.9% | 2.7% | 18% |
| Free-cash-flow yield自由现金流收益率 | 4.5% | 5.5% | 35% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.0% | -0.9% |
| 1 Month近1月 | +3.8% | -0.6% |
| 3 Months近3月 | +11.2% | +5.4% |
| 6 Months近6月 | +3.5% | +8.6% |
| Year to date年初至今 | +11.6% | +8.9% |
| 1 Year近1年 | +70.1% | +19.2% |
| 3 Years近3年 | +109.2% | +69.9% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $3.3B | $4.8B | $4.4B | $4.4B | $4.4B | $4.7B |
| EPS每股收益 | $-1.27 | $-0.97 | $-0.16 | $-2.50 | $0.68 | $-0.47 |
| Free cash flow自由现金流 | $-176M | $357M | $315M | $131M | $394M | $284M |
| Gross margin毛利率 | 49.1% | 55.2% | 56.6% | 56.3% | 54.9% | 55.0% |
| Net margin净利率 | -17.1% | -9.9% | -1.8% | -27.9% | 7.6% | -4.9% |
| FCF margin自由现金流利润率 | -5.4% | 7.5% | 7.1% | 3.0% | 8.9% | 6.0% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: inventory & receivables lean vs sales营运资本:存货与应收相对销售保持精简
- Pricing power: soft gross profitability vs peers定价能力:毛利能力弱于同业
- Capital discipline: share count +5.3% over 6 years (dilution)资本纪律:股本 6 年增加 5.3%(稀释)
- Balance sheet: Altman Z 1.39 — distress zone资产负债表:Altman Z 1.39——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -0.5% | 3 |
| Feb2月 | 67% | +8.0% | 3 |
| Mar3月 | 33% | -5.5% | 3 |
| Apr4月 | 0% | -7.6% | 3 |
| May5月 | 100% | +32.4% | 3 |
| Jun6月 | 50% | +4.0% | 4 |
| Jul7月 | 50% | +2.3% | 4 |
| Aug8月 | 100% | +18.0% | 3 |
| Sep9月 | 33% | -4.5% | 3 |
| Oct10月 | 33% | -14.7% | 3 |
| Nov11月 | 100% | +5.5% | 3 |
| Dec12月 | 33% | -2.3% | 3 |